Sofwave

Advertorial: Addressing GLP-1 Related Skin Laxity with Sofwave

Addressing GLP-1 Related Skin Laxity with Sofwave: An FDA Cleared, Non-Invasive Solution for Face and Body The rapid rise in GLP-1 medication has fundamentally shifted the aesthetic treatment landscape. As more patients experience significant and sustained weight loss, practitioners are …

To access this post, you must purchase Aesthetics Journal Membership – Annual Elite Membership, Aesthetics Journal Membership – Annual Enhanced Membership or Aesthetics Journal Membership – Basic Membership.

Sofwave introduces full-body muscle stimulation

Aesthetic device company Sofwave has launched its Pure Impact electric muscle stimulation technology. The company explains that Pure Impact can be combined with the original Sofwave device to target skin

Sofwave recognises the top clinics in Southern England

Aesthetic device company Sofwave is sponsoring the Best Clinic South England category at The Aesthetics Awards 2024.The Sofwave Award for Best Clinic South England will recognise top clinics who display commitment to exemplary customer service, patient care and patient safety, …

Latest news

Exploring Key Themes Across The Aesthetics Specialty

BCAM issues warning towards peptide injectables

Abstracts

Advertorial: Aligned for Success: The Power of Strategic Partnerships in Modern Business

Treating Menopausal Skin with PDLLA

Injectable Approach with Trauma-aware Care

New insurance broker launches

Dermalux appoints territory business manager

Obagi Medical debuts new serum

Exploring the Gut-Skin Axis in Aesthetics

Advertorial: Addressing GLP-1 Related Skin Laxity with Sofwave

Sofwave introduces full-body muscle stimulation

Sofwave recognises the top clinics in Southern England